Nuvectis Pharma has dropped plans…
Nuvectis Pharma has dropped plans to develop NXP800 in ovarian [...]
Frazier Life Sciences has gathered…
Frazier Life Sciences has gathered an impressive $1.3 billion in [...]
The FDA has missed the date for…
The FDA has missed the date for Coya Therapeutics’ investigational [...]
Weeks after the biotech gave up on…
Weeks after the biotech gave up on a psoriasis trial [...]
Cardiff Oncology has reported…
Cardiff Oncology has reported updated results from its phase 2 [...]
As Merck & Co. rolls out a…
As Merck & Co. rolls out a widespread cost-cutting initiative, [...]
Quoin Pharmaceuticals has ended…
Quoin Pharmaceuticals has ended development of two programs, pulling back [...]
Bausch Health has struck a deal to…
Bausch Health has struck a deal to buy Durect for [...]
After assuring investors last week…
After assuring investors last week that beleaguered Sarepta Therapeutics would [...]
After months of searching for…
After months of searching for strategic options, Adaptimmune is offloading [...]